Suggestions
Toby Basey-Fisher
CEO - Entia Ltd
Toby Basey-Fisher is an accomplished professional with a wealth of experience in the field of Biomedical Physics.
Having a strong academic background, Toby pursued a Doctor of Philosophy (PhD) in Biomedical Physics at Imperial College London, where he was awarded the Constance Fligg Tipper Centenary Memorial Prize. He also holds a BSc in Physics with First Class Honors from the University of Exeter.
Currently, Toby serves as the CEO of Entia Ltd, showcasing his leadership and management skills in driving the company's success.
Prior to his role at Entia, he held esteemed positions including Executive Board Member at the British In Vitro Diagnostics Association (BIVDA), Honorary Lecturer at Imperial College London, and Enterprise Fellow at both the Royal Academy of Engineering and Imperial College London.
Toby Basey-Fisher's contributions and expertise have made a significant impact in the realm of Biomedical Physics and business leadership.
Highlights
Interesting to see recent statistics from a study carried out by The Health Foundation on perceptions of AI in healthcare:
- 76% of NHS workers who were surveyed support using AI in patient care
- 54% of the public support the use of AI for patient care
- 81% of NHS staff favour the use of AI for administrative tasks
The next decade is going to see a wealth of new AI innovations in healthcare, from diagnosis through to treatment and aftercare. So while it's great to see significant buy-in from those working in healthcare, it remains important to build trust with those at the receiving end of care. Transparency of AI-driven decision-making and the risk of further distancing of patient and healthcare professionals are cited as significant concerns of the public; concerns I've also heard echoed by many doctors and nurses.
I believe that the former challenge of providing transparency in AI decision-making is already front of mind for many companies developing solutions. However, I am particularly curious over the loss of human connection due to AI, sadly because I think it may be an inevitability.
In most countries we are dealing with a lack of healthcare professionals. And while automation of tasks can provide some time back to healthcare professionals for patient engagement, I believe that patient demand will still outstrip capacity. Consequently, we will have to accept that some patient engagement must happen through new mechanisms.
It therefore becomes important for us to understand exactly where the most valuable moments are for human interaction and what would be the least impactful to let go of. I'm fine telling a chatbot how I feel and getting some advice, but I'm not sure I want to be told by it that I've a terminal illness…
#AI #AIhealthcare #Oncology
It's fantastic to see huge milestones like this in remote patient monitoring. Congrats to everyone involved in the Connect Me programme. It's so positive to see people engaged with remote healthcare and it will be interesting to see the long-term impact this has on both patients and healthcare systems.
Whilst there has been considerable investment in these initiatives across elderly care and respiratory, there is still much to be done in cancer care. The launch of Liberty, our at-home oncology blood testing solution, is providing a great foundation from which to empower patients throughout cancer treatment, but there are also other digital innovations that offer huge potential within the UK healthcare system, particularly around well evidenced patient-facing applications and vitals monitoring solutions not dissimilar to this article’s blood pressure cuff.
